Dermot Murnaghan has said he ‘fell through the gaps’ before getting his cancer diagnosis. The former Sky News presenter, 67, ...

LOS ANGELES, CA, USA I July 15 2025 I Kairos Pharma, Ltd. (NYSE American:KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer ...

After he was diagnosed with stage four prostate cancer, Dermot Murnaghan feels like he “fell through the gaps” the regular tests he was having didn't include one for PSA (prostate-specific antigen).

Her new doctor immediately took action, performing a series of tests and soon discovering what others had missed: Avi had ...

Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...

A Flinders University study shows that bowel cancer survivors face an elevated risk of developing multiple primary cancers ...

Although an elevated PSA measurement can indicate prostate cancer, there can be other reasons for elevated levels.

Most men who are treated for prostate cancer according to modern guidelines have good survival rates and the majority of ...

Novartis shares climb on strong Cosentyx sales, franchise growth, and a new malaria drug approval despite political risks.

Kenya’s fight against cancer has entered a new phase, driven by technological breakthroughs that promise to transform diagnosis, treatment, and survival rates.

During a live event, Jahan Aghalar, MD, discussed key NCCN-recommended oral therapies and landmark trials for metastatic prostate cancer.